Exane Derivatives’s Natural Order Acquisition Corp. Unit NOACU Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
$940K Hold
95,000
0.54% 46
2022
Q1
$948K Hold
95,000
0.27% 100
2021
Q4
$963K Hold
95,000
0.23% 96
2021
Q3
$980K Hold
95,000
0.24% 93
2021
Q2
$988K Hold
95,000
0.22% 94
2021
Q1
$999K Buy
95,000
+55,000
+138% +$643K 0.29% 82
2020
Q4
$434K Buy
+40,000
New +$427K 0.13% 187

Other funds holding NOACU

Exane Derivatives's NOACU Position: Q2 2022 in Review

Exane Derivatives held its Natural Order Acquisition Corp. Unit (NOACU) position steady in Q2 2022 at 95,000 shares worth $940K. The position accounts for 0.54% of the portfolio, ranked #46.

Exane Derivatives first reported a position in NOACU in Q4 2020 and has held it in 7 quarters since. The position peaked at $999K in Q1 2021. 13 funds tracked by Wall St. Rank hold NOACU as of Q2 2022.

  • Exane Derivatives held 95,000 shares of Natural Order Acquisition Corp. Unit worth $940K as of Q2 2022.
  • Exane Derivatives left its Natural Order Acquisition Corp. Unit share count unchanged in Q2 2022.
  • Natural Order Acquisition Corp. Unit made up 0.54% of Exane Derivatives's portfolio in Q2 2022, its #46 holding.
  • Exane Derivatives first reported a position in Natural Order Acquisition Corp. Unit in Q4 2020 and has held it in 7 quarters since.
  • Exane Derivatives's Natural Order Acquisition Corp. Unit position peaked at $999K in Q1 2021.
  • 13 funds tracked by Wall St. Rank held Natural Order Acquisition Corp. Unit as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.